ADD ANI AS A TRUSTED SOURCE
googleads
Menu
Asia

S Korea: 35 million doses of COVID vaccines to be supplied in July-August

Seoul [South Korea], July 16 (ANI/Global Economic): The Korean government announced that it has secured 21.5 million doses of COVID-19 vaccines and is going to supply 35 million doses of vaccine from Friday (July 16) to the end of August.

ANI Jul 16, 2021 12:15 IST googleads

42 million doses will be provided in September. (Photo: NEWSIS)

Seoul [South Korea], July 16 (ANI/Global Economic): The Korean government announced that it has secured 21.5 million doses of COVID-19 vaccines and is going to supply 35 million doses of vaccine from Friday (July 16) to the end of August.
Bae Kyung Taek, the general situation team director of Central Disease Control Headquarters (CDCH) announced at regular briefing held on July 15, "799,000 doses of Pfizer vaccine arrived on July 14, and total 21.5 million doses of vaccine were secured as of July 15. 2.88 million doses of vaccines which were scheduled to be supplied in July have been secured."
According to the COVID-19 vaccination response team, a total of 2.88 million doses of vaccines were secured in July, including 2.127 million doses of Pfizer vaccine and about 750,000 doses of Moderna vaccine.
The government will supply 35 million doses of vaccines from today to the end of August, and about 42 million doses in September.
The vaccines supplied in July and August includes Astrazeneca (AZ), Pfizer, Moderna and Jansen. (ANI/Global Economic)

Get the App

What to Read Next

Asia

India consistently supported Maldives in crisis: Mohamed Nasheed

India consistently supported Maldives in crisis: Mohamed Nasheed

He highlighted India's role as a "first responder" for the Maldives, emphasising that India's support during critical periods has been fundamental to the stability and security of the island nation.

Read More
Asia

Policy delays leave Pakistan short of critical medicines

Policy delays leave Pakistan short of critical medicines

Pakistan faces a severe shortage of life-saving medicines, including cancer drugs and vaccines, due to government delays in notifying official prices. While global supply remains stable, regulatory hurdles have stalled legal imports, raising concerns over patient survival and the potential rise of unregulated, counterfeit medicines.

Read More
Asia

"Global South emanates from shared history": EAM Jaishankar

EAM S Jaishankar stated that the era of "big deals" between dominant powers is over, as multipolarity is now an irreversible reality. He argued that the Global South is defined by shared historical experiences, while noting a growing "differentiation" within the previously unified Global West.

Read More
US

KV Subramanian wins prestigious Chicago Alumni Award

KV Subramanian wins prestigious Chicago Alumni Award

The University of Chicago has honoured Professor Krishnamurthy V. Subramanian with the Alumni Award for Professional Achievement. He is the first Indian economist to receive the 85-year-old distinction, recognised for his "landmark" policy work and leadership in India during the COVID-19 crisis and global economic uncertainty.

Read More
Asia

Building resilience through nature: Palladium CEO Amit Patjoshi

Building resilience through nature: Palladium CEO Amit Patjoshi

Opening his remarks, he said, "The subject is quite enriching. There is an old Sanskrit is saying 'Prakriti Rakshit Rakshita' which means nature protects when protected." He noted that the COVID-19 pandemic reinforced this principle, adding, "An example of the same was given by Dr Viva during the covid time and I must say that while framing this session is what exactly right when we talk about how the wetlands the forest catchments close the run up of the floods the mangroves protect it is necessary to understand how such solution can be scaled in a sustainabale mod so that they thrive using the overall public budget."

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.